ArticleJournal of neuroinflammation2025

BAFF is a marker of hypogammaglobulinemia, neuroaxonal damage and inflammation in multiple sclerosis patients on ocrelizumab.

Anastasia Chumakova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.